BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1611305)

  • 1. Matrix vesicles contain metalloproteinases that degrade proteoglycans.
    Dean DD; Schwartz ZV; Muniz OE; Gomez R; Swain LD; Howell DS; Boyan BD
    Bone Miner; 1992 May; 17(2):172-6. PubMed ID: 1611305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.
    Dean DD; Schwartz Z; Muniz OE; Gomez R; Swain LD; Howell DS; Boyan BD
    Calcif Tissue Int; 1992 Apr; 50(4):342-9. PubMed ID: 1571846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.
    Dean DD; Boyan BD; Muniz OE; Howell DS; Schwartz Z
    Calcif Tissue Int; 1996 Aug; 59(2):109-16. PubMed ID: 8687979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta-glycerophosphate and ascorbic acid.
    Dean DD; Schwartz Z; Bonewald L; Muniz OE; Morales S; Gomez R; Brooks BP; Qiao M; Howell DS; Boyan BD
    Calcif Tissue Int; 1994 May; 54(5):399-408. PubMed ID: 8062158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D regulation of metalloproteinase activity in matrix vesicles.
    Dean DD; Schwartz Z; Schmitz J; Muniz OE; Lu Y; Calderon F; Howell DS; Boyan BD
    Connect Tissue Res; 1996; 35(1-4):331-6. PubMed ID: 9084672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinase activity in growth plate chondrocyte cultures is regulated by 1,25-(OH)(2)D(3) and 24,25-(OH)(2)D(3) and mediated through protein kinase C.
    Maeda S; Dean DD; Sylvia VL; Boyan BD; Schwartz Z
    Matrix Biol; 2001 Apr; 20(2):87-97. PubMed ID: 11334710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro.
    Boyan BD; Schwartz Z; Swain LD; Carnes DL; Zislis T
    Bone; 1988; 9(3):185-94. PubMed ID: 3166834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
    Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
    J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.
    Schmitz JP; Schwartz Z; Sylvia VL; Dean DD; Calderon F; Boyan BD
    J Cell Physiol; 1996 Sep; 168(3):570-9. PubMed ID: 8816911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of metalloproteinases in human osteoarthritis.
    Woessner JF; Gunja-Smith Z
    J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix vesicles as a marker of endochondral ossification.
    Boyan BD; Schwartz Z; Swain LD
    Connect Tissue Res; 1990; 24(1):67-75. PubMed ID: 2338026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate.
    Brown CC; Hembry RM; Reynolds JJ
    J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of matrix vesicle phospholipid metabolism is cell maturation-dependent.
    Swain LD; Schwartz Z; Boyan BD
    Bone Miner; 1992 May; 17(2):192-6. PubMed ID: 1319251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities.
    Schwartz Z; Schlader DL; Swain LD; Boyan BD
    Endocrinology; 1988 Dec; 123(6):2878-84. PubMed ID: 3264240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts.
    Overall CM; Wrana JL; Sodek J
    Connect Tissue Res; 1989; 20(1-4):289-94. PubMed ID: 2558843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of arachidonic acid turnover by 1,25-(OH)2D3 and 24,25-(OH)2D3 in growth zone and resting zone chondrocyte cultures.
    Schwartz Z; Swain LD; Ramirez V; Boyan BD
    Biochim Biophys Acta; 1990 Sep; 1027(3):278-86. PubMed ID: 2397237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.
    Boyan BD; Schwartz Z; Carnes DL; Ramirez V
    Endocrinology; 1988 Jun; 122(6):2851-60. PubMed ID: 2836176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific MicroRNAs Found in Extracellular Matrix Vesicles Regulate Proliferation and Differentiation in Growth Plate Chondrocytes.
    Asmussen NC; Cohen DJ; Lin Z; McClure MJ; Boyan BD; Schwartz Z
    Calcif Tissue Int; 2021 Oct; 109(4):455-468. PubMed ID: 33950267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.